Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
7.33
-0.23 (-3.04%)
At close: Jul 19, 2024, 4:00 PM
7.32
-0.01 (-0.14%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $226.33 million as of July 22, 2024. Its market cap has decreased by -11.42% in one year.
Market Cap
226.33M
Enterprise Value
120.38M
1-Year Change
-11.42%
Ranking
Category
Stock Price
$7.33
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $226.33M, a decrease of -3.74%. That is a compound annual growth rate of -2.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 226.30M | 107.23% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.60M | 2.33% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 2seventy bio | 229.78M |
| NeuroPace | 228.99M |
| Delcath Systems | 228.68M |
| ESSA Pharma | 228.03M |
| Aldeyra Therapeutics | 226.96M |
| Butterfly Network | 225.46M |
| 23andMe Holding Co. | 223.75M |
| Zura Bio | 222.48M |